Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging has reported Cash & Equivalents over the past 11 years, most recently at $119.5 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 32.1% to $119.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $119.5 million through Jan 2026, down 32.1% year-over-year, with the annual reading at $145.0 million for FY2025, 14.05% down from the prior year.
  • Cash & Equivalents was $119.5 million for Q1 2026 at Varex Imaging, down from $145.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $205.1 million in Q2 2025 and troughed at $81.5 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $138.8 million (2023), against an average of $134.5 million.
  • Year-over-year, Cash & Equivalents plummeted 48.35% in 2022 and then surged 73.37% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $81.5 million in 2022, then surged by 73.37% to $141.3 million in 2023, then grew by 19.39% to $168.7 million in 2024, then dropped by 14.05% to $145.0 million in 2025, then decreased by 17.59% to $119.5 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Cash & Equivalents are $119.5 million (Q1 2026), $145.0 million (Q4 2025), and $136.4 million (Q3 2025).